{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T01:56:05Z","timestamp":1772848565834,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","award":["K01AI173398"],"award-info":[{"award-number":["K01AI173398"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"US Food and Drug Administration","doi-asserted-by":"publisher","award":["75F40121C00158"],"award-info":[{"award-number":["75F40121C00158"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.vaccine.2025.127638","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T06:49:03Z","timestamp":1755845343000},"page":"127638","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["An analytic approach considering two temporal mechanisms driving breakthrough viral infections after vaccination"],"prefix":"10.1016","volume":"63","author":[{"given":"Amanda","family":"Brucker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jillian H.","family":"Hurst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily C.","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deverick","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E.","family":"Yarrington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin A.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.vaccine.2025.127638_bb0005","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2114228","article-title":"Waning immunity after the BNT162b2 vaccine in Israel","volume":"385","author":"Goldberg","year":"2021","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.vaccine.2025.127638_bb0010","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMc2203165","article-title":"Effectiveness of homologous and heterologous Covid-19 boosters against omicron","volume":"386","author":"Accorsi","year":"2022","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127638_bb0015","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.medj.2021.06.006","article-title":"Real-time analysis of a mass vaccination effort confirms the safety of FDA-authorized mRNA COVID-19 vaccines","volume":"2","author":"McMurry","year":"2021","journal-title":"Med"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127638_bb0020","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s12874-021-01416-5","article-title":"A narrative review on the validity of electronic health record-based research in epidemiology","volume":"21","author":"Gianfrancesco","year":"2021","journal-title":"BMC Med Res Methodol"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127638_bb0025","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/jamia\/ocz148","article-title":"How and when informative visit processes can bias inference when using electronic health records data for clinical research","volume":"26","author":"Goldstein","year":"2019","journal-title":"J Am Med Inform Assoc"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127638_bb0030","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/EDE.0000000000001432","article-title":"On the nature of informative presence Bias in analyses of electronic health records","volume":"33","author":"McGee","year":"2022","journal-title":"Epidemiology"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127638_bb0035","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/cid\/ciab438","article-title":"The effectiveness of the two-dose BNT162b2 vaccine: analysis of real-world data","volume":"74","author":"Chodick","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127638_bb0040","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-4091","article-title":"Effectiveness of vaccination during pregnancy to prevent infant pertussis","volume":"139","author":"Baxter","year":"2017","journal-title":"Pediatrics"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127638_bb0045","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1056\/NEJMoa2117128","article-title":"Effectiveness of Covid-19 vaccines over a 9-month period in North Carolina","volume":"386","author":"Lin","year":"2022","journal-title":"New England J Med"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127638_bb0050","doi-asserted-by":"crossref","first-page":"e2215934","DOI":"10.1001\/jamanetworkopen.2022.15934","article-title":"Analysis of postvaccination breakthrough COVID-19 infections among adults with HIV in the United States","volume":"5","author":"Coburn","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127638_bb0055","article-title":"Influenza viruses and vaccines: the role of vaccine effectiveness studies for evaluation of the benefits of influenza vaccines","volume":"10","author":"Trombetta","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127638_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0261930","article-title":"A systematic review of methodological approaches for evaluating real-world effectiveness of COVID-19 vaccines: advising resource-constrained settings","volume":"17","author":"Teerawattananon","year":"2022","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127638_bb0065","doi-asserted-by":"crossref","first-page":"889","DOI":"10.7150\/ijbs.68973","article-title":"A systematic review of vaccine breakthrough infections by SARS-CoV-2 delta variant","volume":"18","author":"Zhang","year":"2022","journal-title":"Int J Biol Sci"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127638_bb0070","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/21645515.2015.1093263","article-title":"Primary vaccine failure to routine vaccines: why and what to do?","volume":"12","author":"Wiedermann","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"Supplement 5","key":"10.1016\/j.vaccine.2025.127638_bb0075","doi-asserted-by":"crossref","first-page":"S422","DOI":"10.1513\/AnnalsATS.201602-095AW","article-title":"Aging of the immune system. Mechanisms and therapeutic targets","volume":"13","author":"Weyand","year":"2016","journal-title":"Ann Am Thorac Soc"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127638_bb0080","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2024-066190","article-title":"Immunogenicity of monovalent mRNA-1273 and BNT162b2 vaccines in children< 5 years of age","volume":"153","author":"Dalapati","year":"2024","journal-title":"Pediatrics"},{"issue":"51","key":"10.1016\/j.vaccine.2025.127638_bb0085","doi-asserted-by":"crossref","first-page":"12878","DOI":"10.1073\/pnas.1717159115","article-title":"Why the evolution of vaccine resistance is less of a concern than the evolution of drug resistance","volume":"115","author":"Kennedy","year":"2018","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2025.127638_bb0090","series-title":"Viral pathogenesis (third edition)","first-page":"233","article-title":"Chapter 17 - viral evolution: It is all about mutations","author":"Stern","year":"2016"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127638_bb0095","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/oxfordjournals.aje.a009034","article-title":"Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale","volume":"145","author":"Korn","year":"1997","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127638_bb0100","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0895-4356(02)00536-X","article-title":"Age at diagnosis and the choice of survival analysis methods in cancer epidemiology","volume":"56","author":"Cheung","year":"2003","journal-title":"J Clin Epidemiol"},{"issue":"24","key":"10.1016\/j.vaccine.2025.127638_bb0105","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1002\/sim.2098","article-title":"Choice of time-scale in cox\u2019s model analysis of epidemiologic cohort data: a simulation study","volume":"23","author":"Thiebaut","year":"2004","journal-title":"Stat Med"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127638_bb0110","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/sim.2699","article-title":"Choice of time scale and its effect on significance of predictors in longitudinal studies","volume":"26","author":"Pencina","year":"2007","journal-title":"Stat Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25009351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25009351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T14:55:51Z","timestamp":1772808951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25009351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":22,"alternative-id":["S0264410X25009351"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127638","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An analytic approach considering two temporal mechanisms driving breakthrough viral infections after vaccination","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127638","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"127638"}}